Prostate-specific antigen (178-187)

Prostate-specific antigen (178-187) is a synthetic peptide fragment corresponding to amino acid residues 178 through 187 of the human prostate-specific antigen (PSA) protein. As a defined epitope within the PSA sequence, this peptide is of considerable interest in molecular biology, immunology, and cancer research due to its role in prostate tissue specificity and its relevance as a biomarker for prostate-related studies. The peptide's well-characterized sequence allows for precise applications in assays, antibody generation, and structural investigations, supporting a wide range of experimental approaches aimed at understanding PSA function, immunogenicity, and its broader implications in prostate biology.

Epitope mapping: Researchers frequently utilize the PSA (178-187) peptide to map immunogenic regions within the full-length PSA protein. By employing this defined sequence in immunoassays, scientists can delineate antibody binding sites and characterize immune recognition patterns. Such mapping is crucial for identifying dominant epitopes, understanding antigen-antibody interactions, and guiding the development of more specific detection reagents or immunoassays for PSA analysis.

Antibody production: The defined sequence of this peptide makes it an ideal immunogen for raising polyclonal or monoclonal antibodies specific to the 178-187 region of PSA. When conjugated to suitable carrier proteins, it can elicit targeted immune responses in host animals, resulting in the generation of antibodies with high affinity and specificity. These antibodies are subsequently valuable for research applications such as Western blotting, ELISA, immunohistochemistry, and other PSA detection platforms.

Assay development: The PSA (178-187) peptide serves as a reliable standard or control in the optimization and validation of immunoassays designed to detect PSA or its fragments. By incorporating the synthetic peptide into assay protocols, researchers can calibrate detection systems, evaluate assay sensitivity and specificity, and benchmark the performance of diagnostic reagents. Its defined sequence ensures reproducibility and consistency in assay results, which is essential for both basic research and translational studies.

T-cell response studies: The peptide's sequence is also employed in studies of cellular immunity, particularly in the context of antigen presentation and T-cell activation. Investigators use this peptide to assess its ability to bind to major histocompatibility complex (MHC) molecules and stimulate antigen-specific T-cell responses in vitro. Such studies are fundamental for understanding immune surveillance mechanisms in prostate tissue and for exploring potential immunotherapeutic strategies targeting PSA-derived epitopes.

Protein interaction analysis: Beyond immunological applications, the PSA (178-187) peptide can be used in biochemical assays to investigate protein-protein or protein-ligand interactions involving the PSA molecule. By serving as a binding partner or competitor in affinity-based assays, the peptide enables researchers to probe the structural and functional properties of the PSA region it represents, facilitating the study of molecular interactions relevant to prostate biology and PSA's role in physiological or pathological processes.

1. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

3. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

5. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active